Table 7:

JNC VI: Compatible Algorithm for Instituting Pharmacologic Agents

1. Set appropriate blood pressure goals (for most patients, SBP < 140 mm Hg and DBP < 90 mm Hg).

2. Institute lifestyle modifications, including weight loss and salt restriction.

3. If hypertension persists, institute drug treatment. Selection includes the following factors:

Starting with a single agent.

  • Starting dose should be lowered in elderly patients; approximately one half the dose in younger patients.
  • Long-acting formulations are preferred for better compliance.
  • Low-dose combination agents may be helpful in minimizing side effects.
  • Titrate upward and/or add a second agent if goal is not reached after 1 to 2 months (for example, patients in the SHEP trial were seen every month until goal blood pressures were achieved).

4. Specifically with regard to ISH in the elderly, JNC VI recommends first-line therapy selections of long-acting calcium channel blockers, thiazide diuretics, or beta blockers in combination with thiazide diuretics.

5. Other appropriate starting regimens could include beta blockers for patients with tachycardia or previous myocardial infarction, angiotensin-converting enzyme inhibitors in patients with proteinuria or heart failure, or long-acting oral nitrates in patients with angina.

6. We do not recommend alpha adrenergic blockers as first-line agents at this time.

7. In all cases, decisions and regimens must be instituted and tailored in accord with a patient's other comorbid conditions and responses to medication.

Adapted from reference 1.

Copyright 2002 The Cleveland Clinic Foundation

Return to Clinical Management of Isolated Systolic Hypertension